|
Market Closed -
Other stock markets
|
Pre-market 12:28:26 | |||
| 0.35 USD | +20.65% |
|
0.377 | +7.71% |
| 07-16 | Ginkgo Bioworks Partners With Syngenta Crop Protection for new Biologicals | MT |
| 07-09 | Goldman Sachs Adjusts Price Target on Ginkgo Bioworks to $0.30 From $0.80, Maintains Sell Rating | MT |
Ginkgo Bioworks Holdings, Inc. provided revenue guidance for the year 2022. The company continues to expect total revenue of $460 million - $480 million in 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -79.29% | 780M | |
| +25.83% | 47.96B | |
| +44.64% | 41.47B | |
| +0.69% | 42.45B | |
| +30.52% | 31.6B | |
| +22.30% | 28.63B | |
| -6.35% | 28.03B | |
| +49.25% | 14.56B | |
| +49.18% | 14.14B | |
| +3.45% | 12.58B |
GINKGO BIOWORKS HOLDINGS, INC. 
